Search results
Results from the WOW.Com Content Network
Journal of Hypertension is a peer-reviewed medical journal published by Lippincott Williams & Wilkins that was established in 1982. It is the official journal of the International Society of Hypertension and the European Society of Hypertension. The journal is published monthly and includes primary papers, reviews, special reports, and letters.
It was established in 1985 as the Journal of Clinical Hypertension, obtaining its current name in 1988. [2] [3] It was originally published quarterly by Elsevier, [2] which transferred it to Nature Publishing Group beginning in 2008, [4] [5] but the journal is now published monthly by Oxford University Press, [3] which acquired the journal in 2012.
Hypertension is a monthly peer-reviewed scientific journal [1] that was established in 1979. It is published on behalf of the American Heart Association by Lippincott Williams & Wilkins . The editor-in-chief is Rhian M. Touyz.
It was established in 2007 and was published until 2018 by Elsevier on behalf of the American Society of Hypertension, of which it was the official journal. The editor-in-chief was Daniel Levy (National Heart, Lung, and Blood Institute). According to the Journal Citation Reports, the journal had a 2017 impact factor of 2.615. [1]
The Journal of Human Hypertension is a monthly peer-reviewed medical journal covering research into hypertension. It was established in 1987 and is published by Nature Publishing Group . The editor-in-chief is Michael Stowasser ( University of Queensland ).
A diagram explaining factors affecting arterial pressure. Pathophysiology is a study which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood pressure.
Guidelines on the choice of agents and how best to step up treatment for various subgroups in hypertension (high blood pressure) have changed over time and differ between countries. A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines [ 1 ] )
Hypertension is usually treated to achieve a blood pressure of below 140/90 mmHg to 160/100 mmHg. According to one 2003 review, reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21% and reduce the likelihood of dementia , heart failure , and mortality from cardiovascular disease .